Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Tiberghien

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Anti-Cancer Drugs|July 1, 1996
Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assayF Tiberghien, F Loor
The Journal of Antibiotics|July 25, 2000
The potent immunosuppressive cyclosporin FR901459 inhibits the human P-glycoprotein and formyl peptide receptor functionsF Tiberghien, T Wenandy, F Loor
Immunology|December 1, 1994
Influence of the lpr environment on the lymph node cell phenotypes in C57BL/6 nubg and nulpr chimerasF Tiberghien, R Ceredig, F Loor
Journal of Immunological Methods|February 26, 1999
The MultiScreen filtration system to measure chemoattractant-induced release of leukocyte granule enzymes by differentiated HL-60 cells or normal human monocytesF Tiberghien, A Didier, A Bohbot, et al.
Immunology|May 1, 1993
Lack of transfer of lpr-type abnormalities (lymphoproliferation or lymphoid aplasia) in double congenic nude beige mice engrafted with lpr haematopoietic cellsF Tiberghien, F Pflumio, L Kuntz, et al.
Anti-Cancer Drugs|May 1, 1996
Detection of P-glycoprotein expression by tumoral cells with NBDL-CsA, a fluorescent derivative of cyclosporin AA Didier, F Tiberghien, R Wenger, et al.
Autoimmunity|January 1, 1992
Serum immunoglobulin isotype profile of viable and non viable lymphoid cell chimaeras made with nude athymic lpr (lymphoproliferation) mouse recipientsF Tiberghien, B Jachez, E Montecino-Rodriguez, et al.
Annales Francaises D'Anesthesie Et De Reanimation|June 12, 1999
[Right subclavian catheterization. Misplaced insertion into the subclavian artery and the ascending aorta]J L Delacour, S Gury, C Lancrenon, et al.
Journal of Medicinal Chemistry|July 13, 2000
Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporterF Tiberghien, T Kurome, K Takesako, et al.
Revue Neurologique|May 2, 2002
[Candida albicans meningoencephalomyeloradiculitis]F Tiberghien, J De Seze, T Stojkovic, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|July 1, 1996
Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assayF Tiberghien, F Loor
The Journal of Antibiotics|July 25, 2000
The potent immunosuppressive cyclosporin FR901459 inhibits the human P-glycoprotein and formyl peptide receptor functionsF Tiberghien, T Wenandy, F Loor
Immunology|December 1, 1994
Influence of the lpr environment on the lymph node cell phenotypes in C57BL/6 nubg and nulpr chimerasF Tiberghien, R Ceredig, F Loor
Journal of Immunological Methods|February 26, 1999
The MultiScreen filtration system to measure chemoattractant-induced release of leukocyte granule enzymes by differentiated HL-60 cells or normal human monocytesF Tiberghien, A Didier, A Bohbot, et al.
Immunology|May 1, 1993
Lack of transfer of lpr-type abnormalities (lymphoproliferation or lymphoid aplasia) in double congenic nude beige mice engrafted with lpr haematopoietic cellsF Tiberghien, F Pflumio, L Kuntz, et al.
Anti-Cancer Drugs|May 1, 1996
Detection of P-glycoprotein expression by tumoral cells with NBDL-CsA, a fluorescent derivative of cyclosporin AA Didier, F Tiberghien, R Wenger, et al.
Autoimmunity|January 1, 1992
Serum immunoglobulin isotype profile of viable and non viable lymphoid cell chimaeras made with nude athymic lpr (lymphoproliferation) mouse recipientsF Tiberghien, B Jachez, E Montecino-Rodriguez, et al.
Annales Francaises D'Anesthesie Et De Reanimation|June 12, 1999
[Right subclavian catheterization. Misplaced insertion into the subclavian artery and the ascending aorta]J L Delacour, S Gury, C Lancrenon, et al.
Journal of Medicinal Chemistry|July 13, 2000
Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporterF Tiberghien, T Kurome, K Takesako, et al.
Revue Neurologique|May 2, 2002
[Candida albicans meningoencephalomyeloradiculitis]F Tiberghien, J De Seze, T Stojkovic, et al.
Pageof 2